Journal article
The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
- Publication status:
- Published
Actions
Authors
- Journal:
- BLOOD More from this journal
- Volume:
- 96
- Issue:
- 11
- Pages:
- 825A-825A
- Publication date:
- 2000-11-16
- ISSN:
-
0006-4971
- Pubs id:
-
pubs:331337
- UUID:
-
uuid:0b646d3e-469f-4b0f-bff3-cdfb139889a1
- Local pid:
-
pubs:331337
- Source identifiers:
-
331337
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 2000
If you are the owner of this record, you can report an update to it here: Report update to this record